CN115624593A - Plaster for treating wound and preparation method thereof - Google Patents

Plaster for treating wound and preparation method thereof Download PDF

Info

Publication number
CN115624593A
CN115624593A CN202210490808.7A CN202210490808A CN115624593A CN 115624593 A CN115624593 A CN 115624593A CN 202210490808 A CN202210490808 A CN 202210490808A CN 115624593 A CN115624593 A CN 115624593A
Authority
CN
China
Prior art keywords
parts
plaster
vaseline
treating
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210490808.7A
Other languages
Chinese (zh)
Inventor
林健明
林浩翔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202210490808.7A priority Critical patent/CN115624593A/en
Publication of CN115624593A publication Critical patent/CN115624593A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/28—Mercury; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/238—Saposhnikovia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/739—Sanguisorba (burnet)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/898—Orchidaceae (Orchid family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a plaster for treating wounds and a preparation method thereof, wherein the plaster comprises the following raw materials in parts by weight: 1-3 parts of calamine, 0.4-0.6 part of borneol, 0.8-1.2 parts of rosin, 0.08-0.15 part of cinnabar, 0.4-0.6 part of pseudo-ginseng, 1.4-1.6 parts of bletilla striata, 1.3-1.6 parts of garden burnet charcoal, 0.8-1.2 parts of divaricate saposhnikovia root, 0.4-0.6 part of Chinese angelica and 40-60 parts of vaseline, and the preparation method comprises the following specific steps of S1, weighing calamine, borneol, rosin, cinnabar, pseudo-ginseng, bletilla striata, garden burnet charcoal, divaricate saposhnikovia root and Chinese angelica according to the parts by weight, mixing and grinding to form medicinal powder for later use; s2, weighing vaseline in parts by weight, and heating; and S3, stirring and mixing the medicinal powder and the heated vaseline, and cooling to room temperature to obtain the plaster for treating the wound. The plaster can effectively relieve the pain of patients with wounds, can be used for patients with different degrees of wounds, helps the skin of the patients to heal quickly, and has good effect on the patients with different degrees of burns and scalds.

Description

Plaster for treating wound and preparation method thereof
Technical Field
The invention relates to the technical field of plaster, in particular to a plaster for treating wounds and a preparation method thereof.
Background
The skin is the tissue of the body surface wrapped outside the muscle, is the largest organ of the human body surface area, and mainly plays the roles of protecting the body, discharging sweat, feeling cold and heat, pressure and the like. The skin covers the whole body and protects various tissues and organs in the body from physical, mechanical, chemical and pathogenic microbial attacks. In daily life, skin injuries of different degrees are easily caused due to external and self factors, skin tissues can be separated or damaged after skin wounds, although the skin has certain self-healing capacity, the skin wounds such as burns and scalds which are not closed up due to old wounds and the skin diseases such as paronychia, tinea pedis, cracking of hands and feet and abrasion need to be treated by medicine intervention, the most commonly used medicine for the skin diseases with the symptoms is the external plaster, but the current external plaster on the market has complex prescription, complicated preparation process and insufficient skin repairing effect.
Disclosure of Invention
In order to solve the problems, the invention adopts the following technical scheme: a plaster for treating wounds is prepared from the following raw materials in parts by weight: 1-3 parts of calamine, 0.4-0.6 part of borneol, 0.8-1.2 parts of rosin, 0.08-0.15 part of cinnabar, 0.4-0.6 part of pseudo-ginseng, 1.4-1.6 parts of bletilla, 1.3-1.6 parts of carbonized sanguisorba root, 0.8-1.2 parts of divaricate saposhnikovia root, 0.4-0.6 part of Chinese angelica and 40-60 parts of vaseline.
Further, the plaster for treating the wound comprises the following raw materials in parts by weight: 3 parts of calamine, 0.4 part of borneol, 0.8 part of rosin, 0.15 part of cinnabar, 0.6 part of pseudo-ginseng, 1.45 parts of bletilla striata, 1.6 parts of carbonized sanguisorba root, 0.8 part of divaricate saposhnikovia root, 0.45 part of angelica and 40 parts of vaseline.
Further, the plaster for treating the wound comprises the following raw materials in parts by weight: 1 part of calamine, 0.5 part of borneol, 1.2 parts of rosin, 0.1 part of cinnabar, 0.5 part of pseudo-ginseng, 1.4 parts of bletilla striata, 1.3 parts of carbonized sanguisorba root, 1.2 parts of divaricate saposhnikovia root, 0.4 part of Chinese angelica and 45 parts of vaseline.
Further, the plaster for treating the wound comprises the following raw materials in parts by weight: 1.5 parts of calamine, 0.6 part of borneol, 1.1 parts of rosin, 0.08 part of cinnabar, 0.4 part of pseudo-ginseng, 1.6 parts of bletilla striata, 1.45 parts of carbonized sanguisorba root, 1.1 parts of divaricate saposhnikovia root, 0.6 part of angelica and 60 parts of vaseline.
Further, the plaster for treating the wound comprises the following raw materials in parts by weight: 2 parts of calamine, 0.5 part of borneol, 1 part of rosin, 0.1 part of cinnabar, 0.5 part of pseudo-ginseng, 1.5 parts of bletilla, 1.5 parts of carbonized sanguisorba root, 1 part of divaricate saposhnikovia root, 0.5 part of Chinese angelica and 50 parts of vaseline.
A preparation method of a plaster for treating wound comprises the following specific steps:
s1, weighing calamine, borneol, rosin, cinnabar, pseudo-ginseng, bletilla striata, carbonized sanguisorba root, divaricate saposhnikovia root and Chinese angelica according to parts by weight, mixing and grinding to form medicinal powder for later use;
s2, weighing vaseline in parts by weight, and heating;
and S3, stirring and mixing the medicinal powder and the heated vaseline, and cooling to room temperature to obtain the plaster for treating the wound.
The beneficial effects of the invention are as follows: the plaster can effectively relieve the pain of patients with wounds, can be used for patients with different degrees of wounds, helps the skin of the patients to heal quickly, and has good effect on the patients with different degrees of burns and scalds.
Detailed Description
The technical solution of the present invention will be further described below, and the present invention is not limited to the following specific embodiments. It should be noted that the embodiments and features of the embodiments may be combined with each other without conflict.
Specifically, the calamine can be used for astringing dampness, relieving itching and healing sore, and is used for treating unhealed ulcer, dribbling pus and skin itch, the borneol is used for treating sore and swollen pain and unhealed ulcer, the rosin is used for dispelling wind and drying dampness, expelling pus and drawing out pus and promoting granulation and relieving pain, the cinnabar is used for clearing heat and detoxicating and sore and ulcer pyogenic infections, the pseudo-ginseng is used for dissipating blood stasis and stopping bleeding, and relieving swelling and stopping pain, and the bletilla is used for astringing to stop bleeding and relieving swelling and promoting granulation, the sanguisorba officinalis is used for treating blood heat and bleeding, detoxifying and healing sore, burns, eczema and skin ulcer, the ledebouriella root is used for dispelling wind and eliminating dampness, relieving pain and preventing tetanus, and the angelica is used for enriching blood, activating blood and regulating menstruation and relieving pain.
Example 1:
the preparation method of the plaster for treating the wound comprises the following steps:
s1, weighing 3 parts of calamine, 0.4 part of borneol, 0.8 part of rosin, 0.15 part of cinnabar, 0.6 part of pseudo-ginseng, 1.45 parts of bletilla, 1.6 parts of carbonized sanguisorba root, 0.8 part of divaricate saposhnikovia root and 0.45 part of Chinese angelica according to parts by weight, mixing and grinding to form medicinal powder for later use.
Specifically, when all the raw materials are added together, the raw materials are not in sequence, and can be ground manually or by a grinder to finally form medicinal powder for later use.
S2, weighing 40 parts of vaseline by weight and heating.
Specifically, vaseline is put into a heating vessel, and then heated to a boiling state.
And S3, stirring and mixing the medicinal powder and the heated vaseline, and cooling to room temperature to obtain the plaster for treating the wound.
Specifically, the ground medicinal powder is directly poured into the freshly heated Vaseline, is manually stirred, is directly kept stand and cooled after being uniformly stirred, and is finally cooled to room temperature to obtain the plaster.
Example 2:
the preparation method of the plaster for treating the wound comprises the following steps:
s1, weighing 1 part of calamine, 0.5 part of borneol, 1.2 parts of rosin, 0.1 part of cinnabar, 0.5 part of pseudo-ginseng, 1.4 parts of bletilla, 1.3 parts of carbonized sanguisorba root, 1.2 parts of divaricate saposhnikovia root and 0.4 part of Chinese angelica according to the parts by weight, mixing and grinding to form medicinal powder for later use.
Specifically, when all the raw materials are added together, the raw materials are not in sequence, and can be ground manually or by a grinder to finally form medicinal powder for later use.
S2, weighing 45 parts of vaseline by weight and heating.
Specifically, vaseline is put into a heating vessel, and then heated to a boiling state.
And S3, stirring and mixing the medicinal powder and the heated vaseline, and cooling to room temperature to obtain the plaster for treating the wound.
Specifically, the ground medicinal powder is directly poured into the heated Vaseline, and is stirred manually, and after the mixture is stirred uniformly, the mixture is directly kept stand for cooling, and finally the mixture is cooled to room temperature to obtain the plaster.
Example 3:
the preparation method of the plaster for treating the wound comprises the following steps:
s1, weighing 1.5 parts of calamine, 0.6 part of borneol, 1.1 part of rosin, 0.08 part of cinnabar, 0.4 part of pseudo-ginseng, 1.6 parts of bletilla, 1.45 parts of garden burnet charcoal, 1.1 parts of divaricate saposhnikovia root and 0.6 part of Chinese angelica according to parts by weight, mixing and grinding to form medicinal powder for later use.
Specifically, when all the raw materials are added together, the raw materials are not in sequence, and can be ground manually or by a grinder to finally form medicinal powder for later use.
S2, weighing 60 parts of vaseline by weight and heating.
Specifically, vaseline is put into a heating vessel, and then heated to a boiling state.
And S3, stirring and mixing the medicinal powder and the heated vaseline, and cooling to room temperature to obtain the plaster for treating the wound.
Specifically, the ground medicinal powder is directly poured into the heated Vaseline, and is stirred manually, and after the mixture is stirred uniformly, the mixture is directly kept stand for cooling, and finally the mixture is cooled to room temperature to obtain the plaster.
Example 4:
the preparation method of the plaster for treating the wound comprises the following steps:
s1, weighing 2 parts of calamine, 0.5 part of borneol, 1 part of rosin, 0.1 part of cinnabar, 0.5 part of pseudo-ginseng, 1.5 parts of bletilla, 1.5 parts of carbonized sanguisorba root, 1 part of divaricate saposhnikovia root and 0.5 part of Chinese angelica according to parts by weight, mixing and grinding to form medicinal powder for later use.
S2, weighing 50 parts of vaseline by weight and heating.
Specifically, vaseline is put into a heating vessel, and then heated to a boiling state.
And S3, stirring and mixing the medicinal powder and the heated vaseline, and cooling to room temperature to obtain the plaster for treating the wound.
Specifically, the ground medicinal powder is directly poured into the heated Vaseline, and is stirred manually, and after the mixture is stirred uniformly, the mixture is directly kept stand for cooling, and finally the mixture is cooled to room temperature to obtain the plaster.
Plaster clinical experiment 1:
60 patients with the same degree of bruise were randomly selected and divided into 6 groups, the first group was externally applied with the plaster of the formulation of example 1 of the present invention, the second group was externally applied with the plaster of the formulation of example 2 of the present invention, the third group was externally applied with the plaster of the formulation of example 3 of the present invention, the fourth group was externally applied with the plaster of the formulation of example 4 of the present invention, the fifth group was externally applied with the existing plaster, and the sixth group was externally applied with normal saline.
Grading the pain degree:
mild pain I
Moderate pain II
Severe pain of III
The standard of curative effect is as follows:
NR is ineffective: no significant change in pain compared to before treatment;
partial MR mitigation: pain relief is less than 60%;
AR is significantly alleviated: pain is reduced by 61-90%;
complete remission of CR: the pain is reduced by 91-100%.
Table 1: statistics of clinical analgesic experimental data
Figure BDA0003630878410000051
Clinical experiment 1 showed that the plaster of the present invention has effective rates of 70%, 80% and 90% for patients with abrasions, the plaster of example 4 is the most effective, and the use of the plaster of the present invention has a significant pain alleviation effect compared to the existing plaster of the fifth group and the physiological saline of the sixth group.
Plaster clinical experiment 2:
volunteers A, B and C were randomly selected for burns and scalds, patient a being a first degree burn, patient B being a shallow second degree burn, and patient C being a deep second degree burn, i.e., patient a's burn would damage a portion of the epidermis, patient B would damage the entire epidermis, and patient C would burn deep below the dermal papilla layer but still leave a portion of the dermis and skin appendages, healing being dependent on the skin appendage epithelium. When the plaster of the embodiment 4 of the invention is used by the patient A, the patient B and the patient C at the same time, the patient A can be directly cured after being used for 2 days, the patient B can be directly cured after being used for 6 days, and the patient C can be directly cured after being used for 14 days, namely, the plaster of the invention can play a good role in patients with different degrees of burns and scalds.
Plaster clinical trial 3:
60 patients with cracked hands and feet were randomly selected and divided into 5 groups, the first group was externally applied with the plaster prepared according to the formulation of example 1 of the present invention, the second group was externally applied with the plaster prepared according to the formulation of example 2 of the present invention, the third group was externally applied with the plaster prepared according to the formulation of example 3 of the present invention, the fourth group was externally applied with the plaster prepared according to the formulation of example 4 of the present invention, and the fifth group was externally applied with the existing "vanishing cream" plaster.
The standard of curative effect is as follows:
primary healing, moderate healing and complete healing.
Table 2: statistics of clinical laboratory data
Figure BDA0003630878410000061
In clinical experiment 3, the volunteers of the first group had an average time to complete healing of 7 days, the volunteers of the second group had an average time to complete healing of 6 days, the volunteers of the third group had an average time to complete healing of 7 days, the volunteers of the fourth group had an average time to complete healing of 5 days, and the volunteers of the fifth group had an average time to complete healing of 14 days. That is, the plaster of the present invention has a significant wound-healing effect on patients with cracked hands and feet, and the plaster corresponding to the fourth group is most effective.
It is worth mentioning that the plaster can be used for treating patients who have wounds which are not easy to heal due to diabetes, namely, the patients with diabetes are difficult to heal after the wounds appear, but the wounds can be quickly healed after the plaster is used for the patients, the healing speed of the patients is higher than that of the patients under normal conditions, and the overall effect is good.
In summary, the above embodiments are not intended to be limiting embodiments of the present invention, and modifications and equivalent variations made by those skilled in the art based on the spirit of the present invention are within the technical scope of the present invention.

Claims (6)

1. The plaster for treating the wound is characterized by comprising the following raw materials in parts by weight: 1-3 parts of calamine, 0.4-0.6 part of borneol, 0.8-1.2 parts of rosin, 0.08-0.15 part of cinnabar, 0.4-0.6 part of pseudo-ginseng, 1.4-1.6 parts of bletilla, 1.3-1.6 parts of carbonized sanguisorba root, 0.8-1.2 parts of divaricate saposhnikovia root, 0.4-0.6 part of Chinese angelica and 40-60 parts of vaseline.
2. The plaster for treating the wound according to claim 1, which is prepared from the following raw materials in parts by weight: 3 parts of calamine, 0.4 part of borneol, 0.8 part of rosin, 0.15 part of cinnabar, 0.6 part of pseudo-ginseng, 1.45 parts of bletilla striata, 1.6 parts of carbonized sanguisorba root, 0.8 part of divaricate saposhnikovia root, 0.45 part of Chinese angelica and 40 parts of vaseline.
3. The plaster for treating the wound according to claim 1, which is prepared from the following raw materials in parts by weight: 1 part of calamine, 0.5 part of borneol, 1.2 parts of rosin, 0.1 part of cinnabar, 0.5 part of pseudo-ginseng, 1.4 parts of bletilla striata, 1.3 parts of carbonized sanguisorba root, 1.2 parts of divaricate saposhnikovia root, 0.4 part of angelica and 45 parts of vaseline.
4. The plaster for treating the wound according to claim 1, which is prepared from the following raw materials in parts by weight: 1.5 parts of calamine, 0.6 part of borneol, 1.1 parts of rosin, 0.08 part of cinnabar, 0.4 part of pseudo-ginseng, 1.6 parts of bletilla, 1.45 parts of carbonized sanguisorba root, 1.1 parts of divaricate saposhnikovia root, 0.6 part of Chinese angelica and 60 parts of vaseline.
5. The plaster for treating the wound according to claim 1, which is prepared from the following raw materials in parts by weight: 2 parts of calamine, 0.5 part of borneol, 1 part of rosin, 0.1 part of cinnabar, 0.5 part of pseudo-ginseng, 1.5 parts of bletilla striata, 1.5 parts of carbonized sanguisorba root, 1 part of divaricate saposhnikovia root, 0.5 part of Chinese angelica and 50 parts of vaseline.
6. The preparation method of the plaster for treating the wound is characterized by comprising the following specific steps of:
s1, weighing calamine, borneol, rosin, cinnabar, pseudo-ginseng, bletilla striata, carbonized sanguisorba root, divaricate saposhnikovia root and Chinese angelica according to parts by weight, mixing and grinding to form medicinal powder for later use;
s2, weighing vaseline in parts by weight, and heating;
and S3, stirring and mixing the medicinal powder and the heated vaseline, and cooling to room temperature to obtain the plaster for treating the wound.
CN202210490808.7A 2022-05-07 2022-05-07 Plaster for treating wound and preparation method thereof Pending CN115624593A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210490808.7A CN115624593A (en) 2022-05-07 2022-05-07 Plaster for treating wound and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210490808.7A CN115624593A (en) 2022-05-07 2022-05-07 Plaster for treating wound and preparation method thereof

Publications (1)

Publication Number Publication Date
CN115624593A true CN115624593A (en) 2023-01-20

Family

ID=84902825

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210490808.7A Pending CN115624593A (en) 2022-05-07 2022-05-07 Plaster for treating wound and preparation method thereof

Country Status (1)

Country Link
CN (1) CN115624593A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1403097A (en) * 2002-10-18 2003-03-19 武汉马应龙药业集团股份有限公司 Sore ulcer treating ointment and its prepn
CN102743484A (en) * 2012-07-09 2012-10-24 中南大学湘雅三医院 Plaster for treating skin disorder and preparation method thereof
CN102908524A (en) * 2012-10-25 2013-02-06 车延西 External application Chinese medicine for treating burn and scald and use method thereof
CN107007712A (en) * 2017-04-11 2017-08-04 重庆大学 Treat the externally applied drug of skin burn
CN110693954A (en) * 2019-11-04 2020-01-17 宫鹏 Preparation method of ointment

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1403097A (en) * 2002-10-18 2003-03-19 武汉马应龙药业集团股份有限公司 Sore ulcer treating ointment and its prepn
CN102743484A (en) * 2012-07-09 2012-10-24 中南大学湘雅三医院 Plaster for treating skin disorder and preparation method thereof
CN102908524A (en) * 2012-10-25 2013-02-06 车延西 External application Chinese medicine for treating burn and scald and use method thereof
CN107007712A (en) * 2017-04-11 2017-08-04 重庆大学 Treat the externally applied drug of skin burn
CN110693954A (en) * 2019-11-04 2020-01-17 宫鹏 Preparation method of ointment

Similar Documents

Publication Publication Date Title
CN108186711A (en) Promote the pharmaceutical composition of wound healing
CN106728727A (en) It is a kind of to treat ointment of sore and preparation method thereof
CN108578494A (en) A kind of burn and scald Chinese medicine composition and preparation method thereof
CN101797303B (en) Chinese medicinal plaster for treating burns and scalds
WO2012100754A1 (en) Chinese medicine composition for treating stab wounds, burns, and various traumas
CN102357203A (en) Cortex ulmis burn ointment for curing burns
CN102228554B (en) Medicament for treating empyrosis and scalding and preparation method thereof
CN1076622A (en) Blood-activating analgetic plaster for tumour
CN103263451B (en) Traditional Chinese medicine for mainly treating trauma as well as sore and ulcer, preparation method and application of traditional Chinese medicine
CN115624593A (en) Plaster for treating wound and preparation method thereof
CN102274380A (en) External applied medicine for treating burn and scalding
CN1286497C (en) Plaster for treating shank sore
CN110624032A (en) Ointment for treating burns and scalds and preparation method thereof
CN101721578B (en) Traditional Chinese medicine paste for removing necrotic tissue, promoting tissue regeneration and treating burns and scalds
CN1141803A (en) Liniment for easing pain and promoting tissue regeneration
CN1156301C (en) Ointment for treating burn and scald and its preparing process
CN108283670A (en) A kind of pharmaceutical composition and preparation method thereof for treating burn and scald
CN102133324B (en) Ointment for treating skin burn and scald
CN107029072A (en) A kind of Hibisci Paste with antiinflammatory action
CN106692491B (en) Ointment for removing scald and burn scars
CN1903214A (en) Ointment containing red precipitate
CN107050298A (en) A kind of Chinese medicine paste formulation and preparation method for treating burn and scald skin damaged
CN113662995A (en) Traditional Chinese medicine formula for treating burns and scalds
CN116036175A (en) Cold compress composition for treating burns and scalds
CN110613770A (en) External Chinese herbal medicine spray for treating mild burns and scalds

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20230120